Cargando…
Short-term efficacy of calcium fructoborate on subjects with knee discomfort: a comparative, double-blind, placebo-controlled clinical study
Calcium fructoborate (CFB) at a dose of 110 mg twice per day was previously reported to improve knee discomfort during the first 14 days of treatment. In this study, 60 participants with self-reported knee discomfort were randomized into two groups receiving CFB or placebo. Initial levels of knee di...
Autores principales: | Pietrzkowski, Zbigniew, Phelan, Michael J, Keller, Robert, Shu, Cynthia, Argumedo, Ruby, Reyes-Izquierdo, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051624/ https://www.ncbi.nlm.nih.gov/pubmed/24940052 http://dx.doi.org/10.2147/CIA.S64590 |
Ejemplares similares
-
Short-Term Efficacy of Calcium Fructoborate on Subjects with Knee Discomfort: a Comparative, Double-Blind, Placebo-Controlled Clinical Study [Corrigendum]
Publicado: (2021) -
Effects of Calcium Fructoborate on Levels of C-Reactive Protein, Total Cholesterol, Low-Density Lipoprotein, Triglycerides, IL-1β, IL-6, and MCP-1: a Double-blind, Placebo-controlled Clinical Study
por: Rogoveanu, Otilia-Constantina, et al.
Publicado: (2014) -
Calcium Fructoborate for Bone and Cardiovascular Health
por: Mogoşanu, George Dan, et al.
Publicado: (2015) -
A Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Effect of Calcium Fructoborate on Systemic Inflammation and Dyslipidemia Markers for Middle-Aged People with Primary Osteoarthritis
por: Scorei, Romulus, et al.
Publicado: (2011) -
The adjuvant use of calcium fructoborate and borax with etanercept in patients with rheumatoid arthritis: Pilot study
por: Hussain, Saad Abdulrahman, et al.
Publicado: (2016)